The Effectiveness of Influenza Vaccination in Different Groups
- PMID: 26775669
- DOI: 10.1586/14760584.2016.1142878
The Effectiveness of Influenza Vaccination in Different Groups
Abstract
Annual administration of the seasonal influenza vaccine, especially to persons known to be at elevated risk for developing serious complications, is the focus of current efforts to reduce the impact of influenza. The main factors influencing estimated inactivated influenza vaccine efficacy and effectiveness, the results obtained in different population groups, current vaccination strategies and the possible advantages of new vaccines are discussed. The available evidence suggests that influenza vaccines are less effective in the elderly than in young adults, but vaccination is encouraged by public health institutions due to higher mortality and complications. There is no consensus on universal vaccination of children yet economic studies suggest that yearly paediatric vaccination is cost saving. The benefits of herd immunity generated by paediatric vaccination require further study. Newer vaccines should be more and more-broadly protective, stable, easy to manufacture and administer and highly immunogenic across all population groups.
Keywords: Influenza vaccines; effectiveness; efficacy; risk groups; study design; vaccination policies.
Similar articles
-
Vaccines for seasonal and pandemic influenza.J Infect Dis. 2006 Nov 1;194 Suppl 2:S111-8. doi: 10.1086/507544. J Infect Dis. 2006. PMID: 17163383
-
Seasonal influenza vaccination of high-risk adults.Expert Rev Vaccines. 2016 Dec;15(12):1507-1518. doi: 10.1080/14760584.2016.1188696. Epub 2016 May 27. Expert Rev Vaccines. 2016. PMID: 27169689 Review.
-
Seasonal influenza vaccines.Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Curr Top Microbiol Immunol. 2009. PMID: 19768400 Review.
-
Universal influenza vaccination in the United States: are we ready? Report of a meeting.J Infect Dis. 2006 Nov 1;194 Suppl 2:S147-54. doi: 10.1086/507556. J Infect Dis. 2006. PMID: 17163388
-
Inactivated influenza virus vaccines in children.Clin Infect Dis. 2004 Mar 1;38(5):678-88. doi: 10.1086/382883. Epub 2004 Feb 17. Clin Infect Dis. 2004. PMID: 14986252 Review.
Cited by
-
Integrating molecular point-of-care testing for influenza into primary care: a mixed-methods feasibility study.Br J Gen Pract. 2020 Jul 30;70(697):e555-e562. doi: 10.3399/bjgp20X710897. Print 2020 Aug. Br J Gen Pract. 2020. PMID: 32661013 Free PMC article.
-
Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase-induced inflammation.J Allergy Clin Immunol. 2018 Sep;142(3):844-856. doi: 10.1016/j.jaci.2017.10.032. Epub 2017 Nov 17. J Allergy Clin Immunol. 2018. PMID: 29155150 Free PMC article.
-
Chronic obstructive pulmonary disease and influenza vaccination effect in preventing outpatient and inpatient influenza cases.Sci Rep. 2022 Mar 22;12(1):4862. doi: 10.1038/s41598-022-08952-0. Sci Rep. 2022. PMID: 35318406 Free PMC article.
-
A Glycolipid α-GalCer Derivative, 7DW8-5 as a Novel Mucosal Adjuvant for the Split Inactivated Influenza Vaccine.Viruses. 2022 May 28;14(6):1174. doi: 10.3390/v14061174. Viruses. 2022. PMID: 35746644 Free PMC article.
-
Adjuvant effects of combination monophosphoryl lipid A and poly I:C on antigen-specific immune responses and protective efficacy of influenza vaccines.Sci Rep. 2023 Jul 28;13(1):12231. doi: 10.1038/s41598-023-39210-6. Sci Rep. 2023. PMID: 37507413 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical